Beta blockers after IM after the expiration date: REDUCE-AMI

Beta blockers after IM after the expiration date: REDUCE-AMI

The REDUCE-AMI trial of beta-blockers after myocardial infarction (MI) had a nonsignificant primary endpoint but is likely to be one of the most important modern trials in cardiology. First we …

Read more

The truth about GLP-1 compounds that doctors need to know

The truth about GLP-1 compounds that doctors need to know

As a cardiologist specializing in obesity medicine, I often encounter patients who would greatly benefit from the new generation of weight loss drugs that work as glucagon-like peptide 1 (GLP-1) …

Read more